Strategic Global Advisors, LLC

Position in ASND — Ascendis Pharma A/S

CIK 1580212 NEWPORT BEACH, CA

Position in ASND

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,042,875

New position

Shares Held

3,910

first reported quarter

Ownership

0.006%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#187

of 307 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Strategic Global Advisors, LLC holds $8,606,227 across 4 Biotechnology names. ASND ranks #3 (12.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	97,747	$5,318,414
2	ALNY	Alnylam Pharmaceuticals, Inc.	4,823	$1,451,867
3	ASND	Ascendis Pharma A/S This page	3,910	$1,042,875
4	ONC	BeOne Medicines Ltd.	2,783	$793,071

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,042,875	3,910	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.